Aortic atherosclerosis is the most common disease of the aortic arch, and patients with complicated aortic atheroma should be considered at risk of stroke. There is indeed controversy about whether and how to treat these patients. This review analyzes the literature data about the epidemiology, the association between atheroma and stroke, the classification of aortic atheroma plaques, the imaging diagnostic process, the therapeutics options, and the clinical trials performed in this clinical setting.
TowfighiA, SaverJL.Stroke declines from third to fourth leading cause of death in the United States: historical perspective and challenges ahead. Stroke. 2011; 42 (8): 2351–2355.
2.
FoulkesMR, WolfPA, PriceTR, . The Stroke Data Bank: design, methods, and baseline characteristics. Stroke. 1988; 19: 547–554.
3.
SaccoRL, EllenbergJH, MohrJP, . Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol. 1989; 25: 382–390.
4.
BogousslavskyJ, PierreP.Ischemic stroke in patients under 45. Neurol Clin. 1992; 10: 113–124.
5.
SteinerMM, Di TullioMR, RundekT, . Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998; 29: 944–948.
6.
SternBJ, KittnerS, SloanM, . Stroke in the young, parts I and II. Md Med J. 1991; 40: 453–462, 565–571.
7.
HommaS, SaccoRL, Di TullioMR, .; PFO in Cryptogenic Stroke Study (PICSS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation. 2002; 105: 2625–2631.
8.
AmarencoP.Patent foramen ovale and the risk of stroke: smoking gun guilty by association?Heart. 2005; 91 (4): 441–443.
9.
AmarencoP.Underlying pathology of stroke of unknown cause (cryptogenic stroke). Cerebrovasc Dis. 2009; 27 (suppl 1): 97–103.
10.
GhoshS, GhoshAK, GhoshSK.Patent foramen ovale and atrial septal aneurysm in cryptogenic stroke. Postgrad Med J. 2007; 83 (977): 173–177.
11.
AmarencoP.Cryptogenic stroke, aortic arch atheroma, patent foramen ovale, and the risk of stroke. Cerebrovasc Dis. 2005; 20 (suppl 2): 68–74.
12.
ThomT, HaaseN, RosamondW, . Heart disease and stroke statistics—2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006; 113: e85–e151.
13.
PezziniA, GrassiM, LodigianiC, .; Italian Project on Stroke in Young Adults Investigators. Interaction between proatherosclerotic factors and right-to-left shunt on the risk of cryptogenic stroke: the Italian Project on Stroke in Young Adults. Heart. 2012; 98 (6): 485–489.
14.
MacleodMR, AmarencoP, DavisSM, . Atheroma of the aortic arch: an important and poorly recognized factor in the etiology of stroke. Lancet Neurol. 2004; 3: 408–414.
15.
JonesEF, KalmanJM, CalafioreP, . Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke. 1995; 26: 218–224.
16.
ThenappanT, JafarAR, AssadM.Aortic atheromas: current concepts and controversies—a review of the literature. Echocardiography. 2008; 25: 198–207.
17.
Di TullioM, RussoC, JinZ, . Aortic arch plaques and risk of recurrent stroke and death. Circulation. 2009; 119: 2376–2382.
18.
MeissnerI, KhandheriaBK, ShepsSG, . Atherosclerosis of the aorta: risk factor, risk marker, or innocent bystander? A prospective population-based transesophageal echocardiography study. J Am Coll Cardiol. 2004; 44: 1018–1024.
19.
AgmonY, KhandheriaBK, MeissnerI, . Relation of coronary artery disease and cerebrovascular disease with atherosclerosis of the thoracic aorta in the general population. Am J Cardiol. 2002; 89: 262–267.
20.
RussoC, JinZ, RundekT, . Atherosclerotic disease of the proximal aorta and the risk of vascular events in a population-based cohort: the Aortic Plaques and Risk of Ischemic Stroke (APRIS) Study. Stroke. 2009; 40 (7): 2313–2318.
21.
MendelT, PopowJ, HierDB, . Advanced atherosclerosis of the aortic arch is uncommon in ischemic stroke: an autopsy study. Neurol Res. 2002; 24: 491–494.
The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators Committee on Echocardiography. Transesophageal echocardiographic correlates of thromboembolism in high-risk patients with nonvalvular atrial fibrillation. Ann Intern Med. 1998; 128: 639–647.
24.
KaralisDG, ChandrasekaranK, VictorMF, . Recognition and embolic potential of intraaortic atherosclerotic debris. J Am Coll Cardiol. 1991; 17: 73–78.
25.
TunickPA, RosenzweigBP, KatzES, . High risk for vascular events in patients with protruding aortic atheromas: a prospective study. J Am Coll Cardiol. 1994; 23: 1085–1090.
26.
AmarencoP, DuyckaertsC, TzourioC, . The prevalence of ulcerated plaques in the aortic arch in patients with stroke. N Engl J Med. 1992; 326: 221–225.
27.
FujimotoS, YasakaM, OtsuboR, . Aortic arch atherosclerotic lesions and the recurrence of ischemic stroke. Stroke. 2004; 35: 1426–1429.
28.
FerrariE, VidalR, ChevallierT, . Atherosclerosis of the thoracic aorta and aortic debris as a marker of poor prognosis: benefit of oral anticoagulants. J Am Coll Cardiol. 1999; 33: 1317–1322.
29.
MituschR, TepeC, StierleU, . [Determinants of arterial embolism with special reference to atheromatous changes of the thoracic aorta]. Z Kardiol. 1995; 84: 198–204.
30.
The French Study of Aortic Plaques in Stroke Group. Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med. 1996; 334: 1216–1221.
31.
Di TullioMR, SaccoRL, SavoiaMT, . Aortic atheroma morphology and the risk of ischemic stroke in a multiethnic population. Am Heart J. 2000; 139: 329–336.
32.
KazuiS, LeviCR, JonesEF, . Risk factors for lacunar stroke: a case-control transesophageal echocardiographic study. Neurology. 2000; 54: 1385–1387.
33.
MontgomeryDH, VerverisJJ, McGoriskG, . Natural history of severe atheromatous disease of the thoracic aorta: a transesophageal echocardiographic study. J Am Coll Cardiol. 1996; 27 (1): 95–101.
34.
TunickPA, PerezJL, KronzonI.Protruding atheromas in the thoracic aorta and systemic embolization. Ann Intern Med. 1991; 115: 423–427.
35.
CastellanosM, SerenaJ, SeguraT, . Atherosclerotic aortic arch plaques in cryptogenic stroke: a microembolic signal monitoring study. Eur Neurol. 2001; 45 (3): 145–150.
36.
MituschR, DohertyC, WucherpfennigH, . Vascular events during follow-up in patients with aortic arch atherosclerosis. Stroke. 1997; 28: 36–39.
37.
SenS, HinderliterA, SenPK, . Aortic arch atheroma progression and recurrent vascular events in patients with stroke or transient ischemic attack. Circulation. 2007; 116 (8): 928–935.
38.
Dávila-RománVG, BarzilaiB, WareingTH, . Atherosclerosis of the ascending aorta. Prevalence and role as independent predictor of cerebrovascular events in cardiac patients. Stroke. 1994; 25: 2010–2016.
39.
AmanuallahAM, ArtelBJ, Gross- manLB, . Usefulness of complex atherosclerotic plaque in the ascending aorta and arch for predicting cardiovascular events. Am J Cardiol. 2002; 89: 1423–1426.
40.
KhathibzadehM, MituschR, StierleU, . Aortic atherosclerotic plaques as a source of systemic embolism. J Am Coll Cardiol. 1996; 27: 664–669.
41.
PopG, SutherlandGR, KoudstaalPJ, . Transesophageal echocardiography in the detection of intracardiac embolic sources in patients with transient ischemic attacks. Stroke. 1990; 21: 560–565.
42.
FasseasP, BrilakisES, LeybishkisB, . Association of carotid artery intima-media thickness with complex aortic atherosclerosis in patients with recent stroke. Angiology. 2002; 53: 185–189.
NamHS, HanSW, LeeJY, . Association of aortic plaque with intracranial atherosclerosis in patients with stroke. Neurology. 2006; 67: 1184–1188.
45.
KazuiS, LeviCR, JonesEF, . Risk factors for lacunar stroke: a case-control transesophageal echocardiographic study. Neurology. 2000; 54: 1385–1387.
46.
Di TullioMR, SaccoRL, GersonyD, . Aortic atheromas and acute ischemic stroke: a transesophageal echocardiographic study in an ethnically mixed population. Neurology. 1996; 46: 1560–1566.
47.
ParthenakisFI, KochiadakisGE, SkalidisEI, . Aortic atherosclerotic lesions in the thoracic aorta detected by multiplane transesophageal echocardiography as a predictor of coronary artery disease in elderly patients. Clin Cardiol. 2000; 23: 734–739.
48.
DemopoulosLA, TunickPA, BernsteinNE, . Protruding atheromas of the aortic arch in symptomatic patients with carotid artery disease. Am Heart J. 1995; 129: 40–44.
49.
NihoyannopoulosP, JoshiJ, AthanasopoulosG, . Detection of atherosclerotic lesions in the aorta by transesophageal echocardiography. Am J Cardiol. 1993; 71: 1208–1212.
50.
StoneDA, HawkeMW, LaMonteM, . Ulcerated atherosclerotic plaques in the thoracic aorta are associated with cryptogenic stroke: a multiplane transesophageal echocardiographic study. Am Heart J. 1995; 130: 105–108.
51.
TunickP, KronzonI.Embolism from the aorta: atheroemboli and thromboemboli. Curr Treat Options Cardiovasc Med. 2001; 3: 181–185.
52.
CohenA, TzourioC, BertrandB, . Aortic plaque morphology and vascular events: a follow-up study in patients with ischemic stroke. FAPS Investigators. French Study of Aortic Plaques in Stroke. Circulation. 1997; 96 (11): 3838–3841.
53.
CastellanosaM, SerenaaJ, SeguraaT, . Atherosclerotic aortic arch plaques in cryptogenic stroke: a microembolic signal monitoring study. Eur Neurol. 2001; 45: 145–150.
54.
MeissnerI, WhisnantJP, KhandheriaBK, . Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc. 1999; 74 (9): 862–869.
55.
OsranekM, PilipA, PatelP, . Amounts of aortic atherosclerosis in patients with aortic stenosis as determined by transesophageal echocardiography. Am J Cardiol. 2009; 103: 713–717.
56.
Kassem-MoussaH, MahaffeyKW, GraffagninoC, .; SYMPHONY and 2nd SYMPHONY Investigators. Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome. Am Heart J. 2004; 148 (3): 439–446.
57.
CroninL, MehtaSR, ZhaoF, . Stroke in relation to cardiac procedures in patients with non–ST-elevation acute coronary syndrome (a study involving >18 000 patients). Circulation. 2001; 104: 269–274.
58.
SegalAZ, AbernethyWB, PalaciosIF, . Stroke as a complication of cardiac catheterization (risk factors and clinical features). Neurology. 2001; 56: 975–977.
KahlertP, KnippSC, SchlamannM, . Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation. 2010; 121 (7): 870–878.
62.
Rodés-CabauJ, DumontE, BooneRH, . Cerebral embolism following transcatheter aortic valve implantation: comparison of transfemoral and transapical approaches. J Am Coll Cardiol. 2011; 57 (1): 18–28.
63.
HusseinA, HilalA, HamouiO, . Value of aortic arch analysis during routine transthoracic echocardiography in adults. Eur J Echocardiogr. 2009; 10 (5): 625–629.
64.
De CastroS, Di AngelantonioE, CelottoA, . Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transesophageal echocardiography study. Eur J Echocardiography. 2009; 10: 96–102.
65.
BolotinG, DomanyY, de PeriniL, . Use of intraoperative epiaortic ultrasonography to delineate aortic atheroma. Chest. 2005; 127 (1): 60–65.
66.
MohrJ, ThompsonJL, LazarRM, .; for the Warfarin-Aspirin Recurrent Stroke Study Group. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 2001; 345: 1444–1451.
67.
PitsavosCE, AggeliKI, BarbetseasJD, . Effects of pravastatin on thoracic aortic atherosclerosis in patients with heterozygous familial hypercholesterolemia. Am J Cardiol. 1998; 82 (12): 1484–1488.
68.
DresslerFA, CraigWR, CastelloR, . Mobile aortic atheroma and systemic emboli: efficacy of anticoagulation and influence of plaque morphology on recurrent stroke. J Am Coll Cardiol. 1998; 31 (1): 134–138.
69.
BlackshearAJ, ZabalgoitiaM, PennockG, .; on behalf of the SPAF TEE Investigators. Warfarin safety and efficacy in patients with thoracic aortic plaque and atrial fibrillation. Am J Cardiol. 1999; 83: 453–455.
70.
HankeyGJ.Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke?Stroke. 2002; 33 (6): 1723–1726.
71.
KaralisDG, QuinnV, VictorMF, . Risk of catheter-related emboli in patients with atherosclerotic debris in thoracic aorta. Am Heart J. 1996; 131: 1149–1155.
72.
CortezAF, SakumaTH, LimaRB, . Cholesterol crystal embolization caused by anticoagulant therapy. Int J Dermatol. 2009; 48 (9): 989–990.
73.
VarisJ, KuusniemiK, JärveläinenH. Cholesterol microembolization syndrome: a complication of anticoagulant therapy. CMAJ. 2010; 182 (9): 931–933. Epub2010Mar22.
74.
MollS, HuffmanJ.Cholesterol emboli associated with warfarin treatment. Am J Hematol. 2004; 77 (2): 194–195.
75.
RajamaniK, ChaturvediS, JinZ, .; PICSS-APASS Investigators. Patent foramen ovale, cardiac valve thickening, and antiphospholipid antibodies as risk factors for subsequent vascular events: the PICSS-APASS study. Stroke. 2009; 40 (7): 2337–2342.
76.
Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Practice Guidelines, American Association for Thoracic Surgery, American College of American College of Cardiology Foundation/American Heart Association Task Force on Diagnosis and Management of Patients With Thoracic Aortic Disease. Guidelines for the diagnosis and management of patients with thoracic aortic disease. A report of the 2010 CCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM. Circulation. 2010; 121: e266–e369.
77.
TunickPA, NayarAC, GoodkinGM, .; NYU Atheroma Group. Effect of treatment on the incidence of stroke and other emboli in 519 patients with severe thoracic aortic plaque. Am J Cardiol. 2002; 90 (12): 1320–1325.
78.
GottliebI, AgarwalS, GautamS, . Aortic plaque regression as determined by magnetic resonance imaging with high-dose and low-dose statin therapy. J Cardiovasc Med (Hagerstown). 2008; 9 (7): 700–706.
79.
CortiR, FusterV, FayadZA, . Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol. 2005; 46 (1): 106–112.
SillesenH, AmarencoP, HennericiMG, .; Stroke Prevention by Aggressive Reduction in Cholesterol Levels Investigators. Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke. 2008; 39 (12): 3297–3302.
82.
CriadoE, WallP, LucasP, . Transesophageal echo-guided endovascular exclusion of thoracic aortic mobile thrombi. J Vasc Surg. 2004; 39: 238–242.
83.
FueglistalerP, WolffT, GuerkeL, . Endovascular stent graft for symptomatic mobile thrombus of the thoracic aorta. J Vasc Surg. 2005; 42: 781–783.
84.
PiffarettiG, TozziM, CaronnoR, . Endovascular treatment for mobile thrombus of the thoracic aorta. Eur J Cardiothorac Surg. 2007; 32 (4): 664–666. E-pub2007Aug8.
85.
ZhangW, Abou-ZamzamM, HashishoM, . Staged endovascular stent grafts for concurrent mobile/ulcerated thrombi of thoracic and abdominal aorta causing recurrent spontaneous distal embolization. J Vasc Surg. 2008; 47: 193–196.
86.
SaratzisN, MelasN, SaratzisA, . Minimally invasive endovascular intervention in emergent and urgent thoracic aortic pathologies: single center experience. Hellenic J Cardiol. 2008; 49: 312e9.
87.
LuebkeT, AleksicM, BrunkwallJ.Endovascular therapy of a symptomatic mobile thrombus of the thoracic aorta. Eur J Vasc Endovasc Surg. 2008; 36: 550–552.
88.
RancicZ, PfammatterT, LachatM, . Floating aortic arch thrombus involving the supraaortic trunks: successful treatment with supra-aortic debranching and antegrade endograft implantation. J Vasc Surg. 2009; 50 (5): 1177–1180. Epub2009Jul22.
89.
MartensT, Van HerzeeleI, JacobsB, . Treatment of symptomatic mobile aortic thrombus. Acta Chir Belg. 2010; 110 (3): 361–364.
90.
FanelliF, GazzettiM, BoattaE, . Acute left arm ischemia associated with floating thrombus in the proximal descending aorta: combined endovascular and surgical therapy. Cardiovasc Intervent Radiol. 2011; 34 (1): 193–197. E-pub2010Jan29.
91.
TsilimparisN, HanackU, PisimisisG, . Thrombus in the non-aneurysmal, nonatherosclerotic descending thoracic aorta—an unusual source of arterial embolism. Eur J Vasc Endovasc Surg. 2011; 41 (4): 450–457. E-pub2010Dec8.
92.
HarrisJA, BisKG, GloverJL, . Penetrating atherosclerotic ulcers of the aorta. J Vasc Surg. 1994; 19: 90–98.
93.
TroxlerM, MavorAI, Homer-VanniasinkamS.Penetrating atherosclerotic ulcers of the aorta. Br J Surg. 2001; 88: 1169–1177.
94.
EggebrechtH, BaumgartD, HeroldU, . Multiple penetrating atherosclerotic ulcers of the abdominal aorta: treatment by endovascular stent graft placement. Heart. 2001; 85: 526.
95.
EggebrechtH, BaumgartD, SchmermundA, . Endovascular stent-graft repair for penetrating ulcer of the descending aorta. Am J Cardiol. 2003; 91 (9): 1150–1153.
96.
LauLS, BlanchardDG, HyeRJ.Diagnosis and management of patients with peripheral macroemboli from thoracic aortic pathology. Ann Vasc Surg. 1997; 11 (4): 348–353.
97.
GouëfficY, ChaillouP, PilletJC, . Surgical treatment of nonaneurysmal aortic arch lesions in patients with systemic embolization. J Vasc Surg. 2002; 36 (6): 1186–1193.
RoyseC, RoyseA, BlakeD, . Assessment of thoracic aortic atheroma by echocardiography: a new classification and estimation of risk of dislodging atheroma during three surgical technique. Ann Thorac Cardiovasc Surg. 1998; 4: 72–77.
100.
WilliamsGM, HarringtonD, BurdickJ, . Mural thrombus of the aorta: an important, frequently neglected cause of large peripheral emboli. Ann Surg. 1981; 194: 737–744.
101.
PorembkaDT, JohnsonDJ, FowlRJ, . Descending thoracic aortic thrombus as a cause of multiple system organ failure: diagnosis by transesophageal echocardiography. Crit Care Med. 1992; 20: 1184–1187.
102.
TunickPA, LacknerH, KatzES, . Multiple emboli form a large aortic arch thrombus in a patient with thrombotic diathesis. Am Heart J. 1992; 124: 239–241.
103.
JosephsonGD, TeifenbrunJ, HarveyJ.Thrombosis of the descending thoracic aorta: a case report. Surgery. 1993; 114.
